Navigation Links
Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy
Date:9/15/2008

VEENENDAAL, Netherlands, September 15 /PRNewswire/ --

- Oncentra(R) RT Viewer* Officially to Launch at ESTRO 2008 in Gothenburg, Sweden, September 14-18 and ASTRO 2008, Boston, USA, September 21-24

Nucletron, a knowledge-based leader in radiation oncology today announced the market release of Oncentra RT Viewer. This unique innovation in treatment planning solutions from Nucletron allows clinicians to review radiotherapy plans that are generated with a wide variety of DICOM-compliant treatment planning systems, in a Windows PC-based environment.

Oncentra RT Viewer makes it possible to review and share treatment planning data, such as DICOM RT Images, RT Structure sets, RT Plans and RT doses, on any computer, making it a powerful tool for clinical consulting and peer-to-peer reviewing. Oncentra RT Viewer therefore is a great alternative for reviewing and sharing treatment planning data with paper hardcopies. This solution allows the digital sharing of plans on the hospital's network, or on any other electronic sharing device.

"Oncentra RT Viewer makes data distribution very easy and efficient. It allows reviewing treatment plans and sharing knowledge with colleagues, anywhere and anytime, ultimately resulting in improving patient care," says Paul van den Biggelaar, Director of New Product Development at Nucletron.

Oncentra RT Viewer will be available for demonstration at ESTRO, Nucletron Booth B02:50 from September 14-18, as well as ASTRO, Nucletron Booth 1602 from September 21-24.

* Oncentra RT Viewer is not currently available for sale in North America, pending regulatory clearance.

About Nucletron

Nucletron is a knowledge-based leader in Radiation Oncology, working with clinical teams to realize innovative solutions that improve patient care. Nucletron strives to offer the best possible choice of radiation modalities through integrated products, software and services. Critical to the Nucletron philosop
'/>"/>

SOURCE Nucletron B V
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Nucletron Announces Oncentra(R) Brachy* Treatment Planning Solution for Multimodality Environment
2. Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering
3. CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
4. Simcere Pharmaceutical Group Announces Two Senior Promotions and Appointment of New Vice President of Human Resources
5. Neurobiological Technologies Announces Dates for 2008 Fiscal Year End Financial Results Conference Call and Presentation at MCF Investor Summit
6. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
7. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
8. Signalife Announces Reverse Stock Split, Preferred Stock Dividend and $5 Million Investment
9. Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices
10. Chromos announces shareholder approval of Arrangement
11. Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)...   University of Maryland (UM) Ventures and ... of an exclusive option by Biomecite Diagnostics for the ... diagnostics to detect inflammatory bowel diseases (IBD), such as ... Florian Fricke and James White developed ... of Maryland School of Medicine,s Institute for Genome Sciences ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Histogen, ... on the products of cells grown under simulated ... 105F immunomodulatory treatment candidate for melanoma during the ... taking place May 6-9, 2015 in Atlanta, GA. ... cells produce a soluble material with anti-oncologic properties, ...
(Date:5/5/2015)... 5, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: APTO, TSX: ... for the three months ended March 31, 2015 and ... are in Canadian dollars. Effective July ... from May 31 to December 31. As a result ... is for the three months ended March 31, 2015, ...
(Date:5/5/2015)... DUBLIN , May 05, 2015 /PRNewswire/ ... ) has announced the addition of the ... report to their offering. Macromolecules ... acids undergo separation or are broken into ... biotechnological products. This separation requires various advanced ...
Breaking Biology Technology:Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 2Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 3Novel Immunomodulatory Treatment Induces Apoptosis in Melanoma 2Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 2Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 3Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 4Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 5Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 6Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 7Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 8Global Separation Systems Market in Biotechnology 2015-2019 - Trends and Forecasts for the $28 Billion Market 2
... Syndax Pharmaceuticals, Inc. announced today that data ... entinostat, a novel, oral small molecule inhibitor of class ... in patients with relapsed or refractory Hodgkin,s lymphoma (HL).  ... 6:00 to 8:00 PM PT at the American ...
... ICBS Ltd., (OTCPK: ICBT), updates shareholders. As you ... we feel have the greatest chance of success. They are ... each instance, ICBS has funded the purchase of equipment and ... goals. We have paid for all of their expenses in ...
... 2011  CeNeRx BioPharma, Inc., a clinical stage company ... the central nervous system (CNS), today announced completion ... Soros Biopharmaceutical Fund, L Capital Partners, Pappas Ventures ... CeNeRx plans to use the proceeds to complete ...
Cached Biology Technology:Entinostat Demonstrates Activity in Hodgkin's Lymphoma 2Entinostat Demonstrates Activity in Hodgkin's Lymphoma 3Entinostat Demonstrates Activity in Hodgkin's Lymphoma 4Entinostat Demonstrates Activity in Hodgkin's Lymphoma 5ICBS, Update for Shareholders. 2ICBS, Update for Shareholders. 3CeNeRx BioPharma Completes $4.85 Million Financing 2CeNeRx BioPharma Completes $4.85 Million Financing 3
(Date:4/2/2015)... April 2, 2015 In ... by far outperforms the strongest competitors, showing outstanding ... accuracy, the system is capable of a throughput ... proves up to be ten times faster than ... runner-up performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
(Date:4/1/2015)... --  Medisafe ™, the leading global medication management platform ... and Android smartphones and tablets, announces today ... to allow patients to track and correlate their adherence ... will be able to visualize in real-time how taking ... as glucose levels and blood pressure. "Patients ...
(Date:3/24/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) ... Recognition Market 2015-2019" report to their offering. ... to grow at a CAGR of 23.5 percent over ... present scenario and the growth prospects of the Global ... the market size, the report considers the revenue generated ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... than boys. Every third child of school age prefers soft ... fish and do not think of themselves as being fussy ... taste differently.The findings of the world,s largest study so far ... and what they like have now been published. The study ...
... Society of Japan (PSJ) has chosen Springer to publish ... , starting in January 2009 with Volume 59, Number ... Society and Medical Tribune Co. Ltd. The journal ... includes such publications as Experimental Brain Research ...
... Medical Center have discovered that older people use their ... storing memories, particularly those associated with negative emotions. ... of Psychological Science , is a novel look ... Older adults, average age 70, and younger adults, average ...
Cached Biology News:Girls have superior sense of taste to boys 2Girls have superior sense of taste to boys 3Girls have superior sense of taste to boys 4Springer and the Physiological Society of Japan sign publishing agreement 2Old and young brains rely on different systems to remember emotional content 2
ANTI END CEL LUNG AG...
For the quantitative determination of canine Interleukin 10,(IL-10) concentrations in cell culture supernates, canine serum,and plasma....
EGTA, 50 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
RAT ANTI RAT RT1Au (CLASS I POLYMORPHIC) Immunogen: AO lymphoid cells...
Biology Products: